SERVICES

Archive | Medical

Medical News

Send2Press photowire

MyHearPod Introduces an Amazingly Small Hearing Aid called HP Micro

CORNELIUS, N.C. – Nov. 1 (SEND2PRESS NEWSWIRE) — HearPod Hearing Aids president Randy Wohlers, BC-HIS, announced today the introduction of the HearPod Micro, which is one of the smallest completely in the canal (CIC) hearing aids on the market and designed to be used for open fittings. Open fitting means the hearing aid allows venting […]

Continue Reading
Epeius

Epeius Biotechnologies Affirms Leadership Role in The Development of Genetic Medicine

SAN MARINO, Calif. – Oct. 11 (SEND2PRESS NEWSWIRE) — Epeius Biotechnologies Corporation today announced that Dr. Frederick Hall, President and CEO of Epeius Biotechnologies, has accepted an invitation to speak at the upcoming Global Pharmaceutical Research & Development Summit held on Oct. 24 at 4:10 p.m. (PT) in Anaheim, Calif. Dr. Hall will present the […]

Continue Reading

	 CORNELIUS, NC - Aug. 2 (SEND2PRESS NEWSWIRE) -- HearPod hearing-aid solutions were developed by baby boomers for baby boomers to resolve mild to moderate and high-frequency hearing loss. A uniquely-designed silicone pillow has allowed the manufacturers of HearPod hearing aids to have an incredible edge for dispensing high-end digital hearing aids for hearing-loss treatment.

HearPod, Inc. Leads the Way in Digital Hearing-Aid Technology and Comfortable Design at Affordable Prices

CORNELIUS, NC – Aug. 2 (SEND2PRESS NEWSWIRE) — HearPod hearing-aid solutions were developed by baby boomers for baby boomers to resolve mild to moderate and high-frequency hearing loss. A uniquely-designed silicone pillow has allowed the manufacturers of HearPod hearing aids to have an incredible edge for dispensing high-end digital hearing aids for hearing-loss treatment.

Continue Reading

	 LOS ANGELES, CA - June 12 (SEND2PRESS NEWSWIRE) -- The International Society of Microbial Resistance (ISMR) is focusing attention on MRSA by convening healthcare professionals to discuss the most current information on the rising prevalence and consequences of a family of antibiotic-resistant bacteria known as methicillin-resistant Staphylococcus aureus (MRSA).

MRSA: Addressing the Crisis

LOS ANGELES, CA – June 12 (SEND2PRESS NEWSWIRE) — The International Society of Microbial Resistance (ISMR) is focusing attention on MRSA by convening healthcare professionals to discuss the most current information on the rising prevalence and consequences of a family of antibiotic-resistant bacteria known as methicillin-resistant Staphylococcus aureus (MRSA).

Continue Reading

	 HOUSTON, TX - June 2 (SEND2PRESS NEWSWIRE) -- The International Society of Microbial Resistance (ISMR) is focusing attention, and educating healthcare professionals, on the rising prevalence and consequences of a relatively new family of antibiotic-resistant bacteria known as methicillin-resistant Staphylococcus aureus (MRSA), through a new 2006 MRSA Educational Summit Program. MRSA can cause serious infections in otherwise healthy newborns, children, and adults.

Addressing the MRSA Crisis

HOUSTON, TX – June 2 (SEND2PRESS NEWSWIRE) — The International Society of Microbial Resistance (ISMR) is focusing attention, and educating healthcare professionals, on the rising prevalence and consequences of a relatively new family of antibiotic-resistant bacteria known as methicillin-resistant Staphylococcus aureus (MRSA), through a new 2006 MRSA Educational Summit Program. MRSA can cause serious infections […]

Continue Reading

	 SAN MARINO, CA - Apr. 7 (SEND2PRESS NEWSWIRE) -- Epeius Biotechnologies Corporation announced today that the Philippine Bureau of Food and Drugs (BFAD) has approved an Expanded Access Program for Rexin-G(TM), the lead product of Epeius Biotechnologies, developed for the treatment of metastatic cancer. Following the landmark approval of Rexin-G(TM) for the treatment of all solid tumors, the Expanded Access Program extends the clinical applications of the world's first targeted genetic medicine to many more cancer patients and enables Epeius Biotechnologies to recoup some of the costs of its ongoing clinical trials in Manila.

Expanded Access Program for Rexin-G Provides Genetic Medicine to Cancer Patients, First Revenues for Epeius Biotechnologies

SAN MARINO, CA – Apr. 7 (SEND2PRESS NEWSWIRE) — Epeius Biotechnologies Corporation announced today that the Philippine Bureau of Food and Drugs (BFAD) has approved an Expanded Access Program for Rexin-G(TM), the lead product of Epeius Biotechnologies, developed for the treatment of metastatic cancer. Following the landmark approval of Rexin-G(TM) for the treatment of all […]

Continue Reading

Therapy Partner Automated Billing Solution for Mental Health Professionals Cuts Time and Costs in Half

DENVER, CO – Dec. 13 (SEND2PRESS NEWSWIRE) — Therapy Partner Corporation, offering financial solutions for the mental health marketplace, today announced the launch of Therapy Partner, an online billing, no interest payment plan, and collection solution that supports the unique therapeutic relationship between mental health providers and their clients in a paperless, secure, internet-based environment.

Continue Reading

Media Advisory: New York Times Contributor and Author of Controversial Book on Mercury in Vaccines, Live on AutismToday.Com

DALLAS, TX and ALBERTA, Canada – April 27 (SEND2PRESS NEWSWIRE) — Autism Today announces a live, interactive telephone conference will be held from 6:00 – 8:00 PST this Thursday, April 28th featuring David Kirby, author of ‘Evidence of Harm, A Medical Controversy’ (ISBN: 0-312-32544-0). He will address the question: ‘Does mercury in vaccines cause autism […]

Continue Reading

Part of the Neotrope® News Network, USA. Neotrope.net